MediPharm Labs Inc specializes in extraction and is the first company to get an oil production license without a cultivation license in Canada. CEO Pat McCutcheon explains that MediPharm has the largest extraction footprint in the country and will be doubling its production capacity to over 200,000 kilos by the end of Q1 next year. MediPharm creates pharmaceutical-grade CBD extracts for medical and recreational end product production. MediPharm is going public in mid-September, at just over $82 million. McCutcheon believes there’s great investor value in MediPharm, compared to competitors Neptune (NASDAQ:NEPT) (TSE:NEPT) and Radient (CVE:RTI) (OTCMKTS:RDDTF) (FRA:RD8), because of the company’s existing inventory, customer, base, and plan to generate wholesale and processing revenue.

James West:   Hey, welcome back to Midas Letter Live. My guest this segment is Pat McCutcheon; he’s President and CEO of MediPharm Labs, Inc., which as yet is a privately held company, soon to go public. Pat, welcome.

Pat McCutcheon:    Thanks so much, James. I’m so happy to be on this show. I’ve watched you guys for a long time, and I’m really excited to be here.

James West:   Oh, well thank you. Tell me about MediPharm Labs. What is it that you guys are going to do in the cannabis space that is differentiated from what everybody else is doing?

Pat McCutcheon:    Absolutely. So MediPharm Labs is a really unique company. We’ve been the first company to get an oil production license without first getting cultivation.

James West:   Congratulations.

Pat McCutcheon:    It’s pretty unique in the space, and it took us a number of years to get this, and we had to break the mold of the actual licensing kind of application process with Health Canada. The one big thing was that Health Canada didn’t feel it was ne

Inner Spirit Holdings Ltd (CNSX:ISH) is a retail and franchising company with its own recreational dispensary brand, Spirit Leaf.  Inner Spirit Holdings is the first franchise model within the cannabis retail space with significant industry partnerships. President and CEO Darren Bondar notes one such partnership is with Newstrike Brands Ltd (CVE:HIP) (OTCMKTS:NWKRF) (FRA:0N8), the company with a strategic alliance with the Tragically Hip to distribute the band’s Up Cannabis brand. The deal ensures Up Cannabis-branded customer lounges in Spirit Leaf stores that will also function as education areas highlighting Canadian music and Indigenous reconciliation.

James West:   Welcome back to Midas Letter Live. My guest in this segment is Darren Bondar, President and CEO of Inner Spirit Holdings Ltd., trading on the CSE under the symbol ISH. Darren, welcome.

Darren Bondar: Yeah, thanks for having us.

James West:   Darren, tell me about Inner Spirit Holdings Limited! What is your main business, and how are you going to differentiate yourself

CannTrust Holdings Inc (TSE:TRST) (OTCMKTS:CNTTF) (FRA:C9S) President and COO Brad Rogers discusses the company’s new partnership with Breakthru Beverage Group. Significantly, Breakthru’s parent company is Diageo plc (NYSE:DEO), the largest distributor of alcoholic beverages in Canada. CannTrust has already developed a zero taste, zero calorie water soluble cannabis product that can be added to any beverage or edible and can reproduce it at scale. As a result of this product development and the deal with Breakthru, CannTrust is perfectly positioned to enter the recreational beverage market. Rogers explains some of CannTrust’s CBD-infused medicinal products and addresses the company’s decision to absorb the excise tax for its medical patients.

James West:   Mr. Brad Rogers is here. Brad, come on in, come on in, come on in! Don’t stand on ceremony. How are you?

Brad Rogers:  I’m well, thank you.

Cannabis Compliance Inc Vice President Deepak Anand and Director of Strategic Sales Michael Elkin join James West in the Midas Letter studio to talk about legal issues surrounding federal de-prohibition in Canada. They share their thoughts on a court case in British Columbia between the City of Vancouver and unlicensed dispensaries providing medical cannabis access to patients in terms of its Charter implications. The trio also discuss the legal framework determining which providers can, and which providers cannot, sell cannabis once federal legalization occurs on October 17. Anand believes that the non-medical illegal dispensaries will be subject to stricter enforcement after October 17 as the federal government (through Bill C-45 and Bill C-46), and various provincial governments, have created significant legal frameworks to enforce licensing. The pair suggest allowing pharmacies to distribute medical cannabis is a likely path to addressing both compliance issues and the Charter rights of patients.

James West:   Hey, welcome back to Midas Letter Live. My guests in this segment are returning for second time or the third time – second time, okay – Deepak Anand is Vice President, and Michael Elkin is Director of Strategic Sales for Cannabis Compliance Inc. Gentlemen, welcome back.

Deepak Anand: Thank you, James.

James West:   You guys always have the ear to the ground in what’s going on behind the scenes, and today is no different. I’d like to open the discussion with the idea that there is a lawsuit wending its way through the Supreme Court of British Columbia, or is it Federal Supreme Court?

Deepak Anand: Supreme Court of BC.

James West:   Supreme Court of BC, whereby a group of dispensaries have engaged Messieurs Conroy and Toosa, who are the successful challengers in the MMAR constitutional challenge back in March 2013?

Deepak Anand: Something like that, I believe.

James West:   And the dispensaries are challenging the government’s right to shut down their dispensaries and stop them from providing medical cannabis to medical patients, because they feel they have a constitutional right to do so?

Deepak Anand: So, James, the story is that the City of Vancouver actually has an injunction to shut some of the dispensaries down in Vancouver that have not paid a lot of municipal licensing fees. John Conroy – Craig Toosa is not involved in this file anymore, because he’s been hired by Canopy Growth, unsurprisingly – but, so Doug Conro

Hut 8 Mining Corp (CVE:HUT) (OTCMKTS:HUTMF) is a bitcoin-focused company, providing investors the opportunity to enter the cryptocurrency space, but provides the security of traditional portfolios. CEO Andrew Kiguel provides an update on the current cryptocurrency rally, and suggests that bitcoin has greater staying power over alt coins. Kiguel identifies Hut 8 Mining’s strategic partnership with Bitfury, a crypto technology company, and its Medicine Hat build, which provides a 350 percent increase in the size of the company’s operations, as the reason Hut 8 Mining has performed well and held its value despite volatility in the crypto space. Kiguel explains that Hut 8 Mining is a publicly listed North American company that has been hoarding its bitcoin and is well-positioned if SEC decides ETFs can only purchase newly minted coin.

James West:   Hey, welcome back to Midas Letter Live. My guest this segment is Andrew Kiguel; he is the CEO of Hut 8 Mining Corp., trading on the TSX Venture under the symbol HUT. Andrew, welcome back.

Andrew Kiguel: Thanks for having me back.

James West:   Andrew, the crypto space has been very volatile to say the least, but also quiet, and I’m hoping that you can give us some reason to be excited about it.

Andrew Kiguel:

Co-founder, chairman, and acting CEO Bruce Linton introduces viewers to Canopy Rivers Corporation, a development of Canopy Growth Corporation (TSE:WEED) (NYSE:CGC) (FRA:11L1). The company delivers capital and expertise partnerships to emerging companies with leverage potential for Canopy Rivers. Canopy Rivers is an investment platform that attracted significant institutional investment in its last round of financing because of its experience operating in jurisdictions where cannabis is legal. Linton explains that with Canopy Rivers the goal is multiple investments that show and/or yield upside on total asset equity value. As a result, Canopy Rivers is both about realizing a rate of return for investors while exploring new techniques and technology that could benefit its parent company, Canopy Growth.

James West:   Welcome back to Midas Letter Live. My guest this segment is somebody who you think you know but it’s not going to be in the capacity that you think you know it as. Bruce Linton is here in his capacity as co-founder, chairman, acting CEO of the yet-to-go-public Canopy Rivers.

Bruce Linton: Wow, good intro, James. Well done. Very well done.

James West:   Yeah, I can’t believe I got all that through.

Bruce Linton: Yeah, I know.

James West:   So Bruce, Canopy Rivers is essentially an offshoot of Canopy Growth, but it has its own thing – and what is it?

Bruce Linton: So, how many deals a week do you think we get presented to us that say, ‘We’d like you to participate. We want you to take a chunk, we want you to be helpful, we want your money, we want your expertise, but we don’t want to get purchased.’ All the time. And so that pattern started probably three, four years ago, and over the last couple years we worked through, what are we going to do about that? And the what to do about it was to set up Rivers so that it can take minority interests, deliver capital and expertise, and depending on the circumstance,

Liberty Health Sciences Inc (CNSX:LHS) (OTCMKTS:LHSIF) (FRA:S6UQ) CEO George Scorsis provides an update on the company’s recent activities including its current stock surge, its deal with PAX, and its foray into the Florida market. PAX produces temperature controlled portable cannabis oil vaporizers that Liberty Health will distribute in Florida through its dispensaries. Scorsis discusses the company’s growth in Florida, which includes an increase in total number of patients and a revenue surge of 112 percent. Scorsis explains the benefits of the Florida market, namely friendly tax rates for medical cannabis customers, aging demographics, and a system with 140,000 patients growing at a rate of over 3,000 patients per week. Aphria Inc (TSE:APH) (OTCMKTS:APHQF) (FRA10E) announced recently that it had completed its divestiture of Liberty Health, but because it has a back-in option, Liberty Health retains access to Aphria’s scientific, operational, and capital resources.

James West:   Hey, welcome back to Midas Letter Live. My guest in this segment almost needs no introduction: George Scorsis is the CEO of Liberty Health Sciences Inc., trading on the CSE under the symbol LHS. George, welc

WOW Unlimited Media Inc (CVE:WOW) is an animation production studio with YouTube advertising and subscription orientated revenue streams. President and COO Neil Chakravarti joins James West in the Midas Letter studio to share details of WOW’s recently finalized deal with Bell Media (TSE:BCE). WOW’s kids and youth content production and skill at creating digital platforms for that content caught Bell’s attention, whose media is increasingly consumed on mobile devices. WOW’s consistent revenue growth is a value catalyst for stock price drivers. WOW’s deal with Bell is also an immediate value catalyst as Bell is the largest media business in Canada.

James West:   Hey, welcome back to Midas Letter Live. My guest this segment is Neil Chakravarti; he’s the COO and President of Wow Unlimited, trading on the TSX Venture under the symbol WOW. Neil, welcome back.

Neil Chakravarti:  Thank you, James. Thanks for having me.

James West:   Neil, big news: you closed a deal with Bell Media, who is now a 12 percent shareholder in Wow Unlimited.

Neil Chakravarti:  Yes.

James West:   And that took a l

Analyst Dimitry Zaytsev shares his thoughts on the security options provide investors in a highly volatile market like cannabis. Zaytsev believes there’s very little institutional participation behind the space’s current rally and believes company’s like Tilray are being buoyed by retail momentum players. Zaytsev questions current valuations and sees a lot of execution risk in the Ontario cannabis market because of black market enterprises and the “head start” such operations have over LPs for recreational dollars. Zaytsev anticipates a sell-off soon with subsequent new lower highs and explains what it means for the industry. Zaytsev addresses the mining industry, highlighting junior miners as a potentially lucrative, low-risk investment option.

James West:   Welcome back to Midas Letter Live. My guest this segment is Dmitry Zaytsev. He is an analyst, and he is joining us today to talk technical. Dmitry, welcome to the show.

Dmitry Zaytsev:    Glad to be here, James.

James West:   Dmitry, the reason we started talking in the first place because you had some interesting comments about the technical indicators as it pertains to the cannabis industry in particular, and given the extreme exuberance in the marketplace, which is unexplainable by anything fundamental except that excessive exuberance, there must be some technical indications. So why don’t we start with a bit about who you are and how you came to be an analyst?

Dmitry Zaytsev:    Yeah. So a little bit about myself: I recently graduated, and I’ve had a bunch of different experiences I was very fortunate to have at various boutique investment banks and other shops. I worked at Kinross, the gold mining company. I’ve also had an opportunity to work at Stoic Advisory, and they’re an M&A shop that focuses specifically on the cannabis space. And I’ve personally been investing in the cannabis space since 2016, 2015, around that time, and so I’ve been very interested by the opportunities there.

And I mean, we can talk about technicals, but I’m also very interested in terms of the fundamentals of all these companies, and I’ve been following those very closely, as well as, you know, the equity, derivatives, options, all those kind of things.

James West:   Okay, interesting. So if you started investing in cannabis in 2015, you must be almost ready to retire.

Dmitry Zaytsev:    Yeah, I wish I had a little bit more money when I was a student, that would have been way better! But no, I mean, I’ve done well for myself. A lot of my friends have done very well for themselves, and it’s been a great opportunity riding these waves.

International Cannabrands (CNSX:JUJU.A) (OTCMKTS:GEATF) (FRA:31G) CEO Steve Gormley discusses the company’s new accretive acquisition strategy. International Cannabrands is focused on emerging cannabis brands and recently acquired Seattle-based Riotous, which provides financing services to cannabis cultivators and manufacturers. International Cannabrands is also close to finalizing a deal with California-based La Vida Verde, which offers a suite of popular cannabis brands. Acquiring established brands with strong regional recognition that have the potential to be franchised positions International Cannabrands well for legalization at the federal level in the United States. Gormley discusses Canadian leadership in the cannabis market and believes “the reality is, Bay Street is the Wall Street of the cannabis business, and the Canadians just bushwhacked us and took over.”

James West:   Steve Gormley here has a business called International Cannabrands, which you might remember was featured on one of our podcasts back in February? January? Anyways, I can’t remember the guy’s name we talked to, but he –

Steve Gormley: Jeff Britz. The former CEO.